EyePoint Pharmaceuticals Ownership | Who Owns EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals Ownership Summary
EyePoint Pharmaceuticals is owned by 57.67% institutional investors, 2.77% insiders, and 39.56% retail investors. Cormorant asset management, lp is the largest institutional shareholder, holding 11.91% of EYPT shares. Federated Hermes Kaufmann R is the top mutual fund, with 3.35% of its assets in EyePoint Pharmaceuticals shares.
EYPT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | EyePoint Pharmaceuticals | 57.67% | 2.77% | 39.56% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Cormorant asset management, lp | 8.32M | 11.91% | $118.55M |
| Blackrock funding, inc. /de | 6.79M | 9.67% | $124.01M |
| Suvretta capital management | 6.19M | 8.86% | $88.18M |
| Federated hermes | 6.02M | 8.58% | $109.94M |
| Adage capital partners gp | 5.56M | 7.95% | $79.17M |
| Blackrock | 3.76M | 7.12% | $32.75M |
| Franklin resources | 4.98M | 7.09% | $90.93M |
| Vanguard group | 4.82M | 6.87% | $88.10M |
| Tcg crossover management | 3.57M | 5.11% | $50.87M |
| Paradigm biocapital advisors lp | 2.01M | 2.87% | $28.56M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Cormorant asset management, lp | 8.32M | 8.18% | $118.55M |
| Essex woodlands management | 1.08M | 6.23% | $19.82M |
| Principia wealth advisory | 530.73K | 6.06% | $9.70M |
| 5am venture management | 1.05M | 5.48% | $14.95M |
| Rosalind advisors | 690.00K | 4.43% | $12.61M |
| Patient square capital lp | 780.00K | 3.05% | $14.25M |
| Tcg crossover management | 3.57M | 2.50% | $50.87M |
| Suvretta capital management | 6.19M | 2.26% | $88.18M |
| Artia global partners lp | 628.37K | 1.42% | $8.95M |
| Myda advisors | 300.00K | 0.92% | $4.27M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | 2.01M | 0.81% | 2.01M |
| Blackrock funding, inc. /de | 6.79M | 0.00% | 1.82M |
| Orbimed advisors | 1.80M | 0.60% | 1.80M |
| Federated hermes | 6.02M | 0.18% | 1.60M |
| Vanguard group | 4.82M | 0.00% | 1.03M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -3.18M |
| Perceptive advisors | - | - | -1.54M |
| Adage capital partners gp | 5.56M | 0.13% | -1.24M |
| Octagon capital advisors lp | - | - | -1.09M |
| Finepoint capital lp | - | - | -1.08M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Paradigm biocapital advisors lp | 2.01M | 0.81% | 2.01M | $28.56M |
| Orbimed advisors | 1.80M | 0.60% | 1.80M | $25.58M |
| Axa investment managers | 244.43K | 0.01% | 244.43K | $3.48M |
| Brevan howard capital management lp | 60.64K | 0.00% | 60.64K | $863.53K |
| Marex group | 47.78K | 0.01% | 47.78K | $872.89K |
Sold Out
| Holder | Change |
|---|---|
| Twin peaks wealth advisors | -1.00 |
| Assetmark | -15.00 |
| Continuum advisory | -16.00 |
| Coldstream capital management | -21.00 |
| Park place capital | -23.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 112 | -30.00% | 40,465,600 | -42.11% | 57 | 0.58% | 64 | -15.79% | 24 | -46.67% |
| Sep 30, 2025 | 156 | 9.86% | 65,594,598 | 1.78% | 93 | 1.10% | 76 | 7.04% | 43 | 22.86% |
| Jun 30, 2025 | 147 | -5.16% | 68,901,914 | -5.62% | 98 | 0.90% | 71 | -12.35% | 38 | -15.56% |
| Mar 31, 2025 | 157 | 4.67% | 74,070,140 | -0.48% | 106 | 0.57% | 81 | -16.49% | 46 | 91.67% |
| Dec 31, 2024 | 148 | 2.78% | 74,156,377 | 26.76% | 136 | 1.18% | 95 | 41.79% | 24 | -52.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Federated Hermes Kaufmann R | 2.77M | 3.35% | 733.00K |
| Federated Hermes Kaufmann Growth | 2.77M | 3.35% | 733.00K |
| Vanguard Total Stock Mkt Idx Inv | 2.60M | 3.14% | - |
| Franklin Biotechnology Discv A(acc)USD | 2.19M | 2.65% | - |
| Federated Hermes Kaufmann Small Cap Grow | 1.98M | 2.39% | 497.00K |
| Federated Hermes Kaufmann Small Cap A | 1.98M | 2.39% | 497.00K |
| Vanguard US Total Market Shares ETF | 1.56M | 2.27% | - |
| iShares Russell 2000 ETF | 1.82M | 2.19% | 1.29M |
| Franklin Small Cap Growth SMA | 1.27M | 1.84% | 1.27M |
| Franklin US Small Cap Growth Equity | 1.28M | 1.55% | 110.25K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 04, 2026 | Ribeiro Ramiro | Chief Medical Officer | Sell | $43.57K |
| Feb 17, 2026 | Ribeiro Ramiro | Chief Medical Officer | Sell | $36.55K |
| Jan 05, 2026 | Ribeiro Ramiro | Chief Medical Officer | Sell | $727.32K |
| Dec 04, 2025 | Cormorant Asset Management, LP | Former 10% Owner | Sell | $942.24K |
| Dec 04, 2025 | Lurker Nancy | - | Sell | $140.48K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 3 |
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | - |
| 2025 Q2 | 4 | - |
| 2025 Q1 | - | - |
EYPT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools